NCT03785756 - Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

February 28, 2020

Conditions

Pain

Interventions

DRUG

Ibuprofen 300 mg Oral Tablet

2 × 300 mg tablets at Hours 0 and 12

DRUG

Ibuprofen 200 mg Oral Tablet

2 × 200 mg tablets at Hours 0, 8, and 16

DRUG

Placebo of PR tablet

2 tablets up to four times in 24 hours

DRUG

Placebo of IR tablet

2 tablets up to four times in 24 hours

Trial Locations (1)

JBR Clinical Research, Salt Lake City